Clinical Trial: A Phase ? Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Randomized, Double-Blind, Controlled, Phase ? Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination to Evaluate Efficacy, S
Brief Summary:
A Phase ? Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta)Protein Vaccine (Sf9 Cell) in Booster Vaccination to Evaluate Efficacy, Safety and Immunogenicity
Read more